CELDACH 50MG INJECTION

About

Celdach 50mg Injection, likely a cytotoxic agent such as dacarbazine, is an alkylating agent used in the treatment of various cancers, particularly malignant melanoma and Hodgkin's lymphoma. Its mechanism of action involves metabolic activation in the liver to form an active metabolite that alkylates DNA, leading to DNA strand breaks and inhibition of nucleic acid synthesis. This disruption of DNA function ultimately results in cell cycle arrest and apoptosis in rapidly proliferating cancer cells.

Administered intravenously, Celdach exerts its cytotoxic effects by interfering with the genetic material of cancer cells, preventing their growth and division. The drug's efficacy is often observed in combination regimens, enhancing the overall therapeutic outcome. Due to its systemic nature, careful monitoring of hematological and hepatic parameters is essential to manage potential toxicities. Its role in oncology is significant for specific indications where it has demonstrated clinical benefit.

Uses

• Malignant melanoma
• Hodgkin's Lymphoma (as part of ABVD regimen)
• Soft tissue sarcomas
• Neuroblastoma

Directions For Use

This medication is administered intravenously by a healthcare professional. Do not self-administer.

Benefits

• Effective in treating advanced malignant melanoma.
• A key component in Hodgkin's lymphoma regimens.
• Can induce tumor regression.
• Offers a treatment option for specific rare cancers.
• May prolong survival in responsive patients.
• Well-established in oncology protocols.

Side Effects

• Severe nausea and vomiting
• Myelosuppression (leukopenia, thrombocytopenia)
• Flu-like syndrome (fever, myalgia, malaise)
• Anorexia
• Diarrhea
• Alopecia
• Photosensitivity
• Injection site pain
• Liver dysfunction (veno-occlusive disease)
• Renal impairment (rare)
• Hypersensitivity reactions
• Neurotoxicity (rare)

Safety Measures

• Alcohol - Avoid alcohol as it may exacerbate gastrointestinal side effects or potentially increase liver toxicity.
• Pregnancy - Celdach is teratogenic and embryotoxic; it is contraindicated in pregnancy. Women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is contraindicated due to the potential for serious adverse effects on the infant.
• Liver - Use with extreme caution in patients with hepatic impairment; severe liver toxicity, including veno-occlusive disease, can occur. Monitor liver function closely.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be necessary, and kidney function should be monitored.
• Lung - No specific lung toxicity is commonly associated, but general monitoring for respiratory symptoms is prudent during chemotherapy.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.